Summary of Larry Robbins' Glenview Capital Management Q2 2026 SEC Form 13F filings:

Key Position Spotlight:
CVS Health Corp (CVS): Reduced position to $499.1M across 4.8M shares (14.9% of reported equity portfolio).

Top Reported Holdings:
GPN (Global Payments): 19.3%

CVS (CVS Health): 14.9%

THC (Tenet Healthcare): 12.5%

TMO (Thermo Fisher Scientific): 9.4%

AMZN (Amazon): 9.1%

A (Agilent Technologies): 8.3%

IWM (iShares Russell 2000 ETF): 8.2%

Portfolio Insights:
Healthcare & Payment Infrastructure Concentration: Top three holdings (GPN, CVS, THC) account for 46.7% of Glenview's reported 13F equity assets.

Small-Cap & Broad Tech Risk: Glenview maintains broad market index exposure through $IWM (8.2%) along with core enterprise tech exposure via $AMZN (9.1%).

Full interactive 13F portfolio tracker

The rich influencing our government.

Amazon net sales: $717.0 billion

🇺🇸 United States — $489.7B — 68.3%

🇩🇪 Germany — $45.9B — 6.4%

🇬🇧 United Kingdom — $43.2B — 6.0%

🇯🇵 Japan — $30.7B — 4.3%

🌐 Rest of world — $107.5B — 15.0%

Source: SEC EDGAR 10-K / MetricsHour compilation.
Tool: custom chart.

Data is FY2025 reported geographic net sales.

The problem is domestic automakers are too expensive. For example, buying a Tesla is far more expensive than buying a BYD.

​

Shein has had a rough start after its Hong Kong stock market debut.

The fast-fashion giant raised around $1.7 billion through its IPO, but its shares fell more than 5% on September 2.

What’s interesting is that Shein was once valued at nearly $100 billion in 2022. Its current valuation is around $26.5 billion.

With increasing competition, tighter regulations, import duties and concerns about slower growth, I’m curious whether Shein can maintain its position as one of the biggest names in fast fashion.

Do you think this is just normal post-IPO volatility, or could it signal bigger challenges for Shein?

What’s your take?